is it already settled if high LDL-C in mass lean hyper responders adopting a keto diet…
- User
is it already settled if high LDL-C in mass lean hyper responders adopting a keto diet increases risk for CVD
Assistant
Okay, let's tackle this complex question about Lean Mass Hyper-Responders (LMHRs) and their risk for cardiovascular disease (CVD) when on a ketogenic diet.
The Short Answer: No, it is ABSOLUTELY NOT settled.
This is one of the hottest, most debated, and actively researched topics in nutrition and cardiology right now. There are very strong opinions on both sides, and definitive long-term data is still being collected.
Why It's Not Settled: The Two Camps
To understand why it's not settled, you need to know about the two main perspectives:
1. The Conventional / Mainstream Medical View (The "Default" Stance)
- The Argument: For decades, science has shown a strong link between high LDL-cholesterol (LDL-C) and an increased risk of atherosclerosis (plaque buildup in arteries) and subsequent CVD events (heart attacks, strokes). This link is well-established through:
- Population Studies: People with higher LDL-C, on average, have higher rates of heart disease.
- Genetic Studies: Individuals with genetic mutations that naturally lower LDL-C throughout their lives have significantly lower rates of CVD.
- Intervention Studies: Drugs (like statins) that lower LDL-C reduce CVD risk.
- Applying it to LMHRs: From this perspective, if an LMHR has an LDL-C of 300, 400, or even 500 mg/dL, it's a significant cause for concern, regardless of other factors. The high LDL-C itself is seen as a direct driver of plaque formation. They would argue that LMHRs, despite being lean and otherwise healthy, are putting themselves at risk by maintaining such high LDL-C levels, and should likely lower their dietary fat or consider medication.
2. The Emerging / "Lipid Energy Model" View (Often Associated with the Keto Community)
- The Argument: This view, championed by people like citizen scientist Dave Feldman (who coined "LMHR") and some researchers, suggests that the context of high LDL-C matters enormously.
- Metabolic Health: LMHRs are typically lean, athletic, have excellent insulin sensitivity, very low triglycerides (TG), and high HDL-C. These are all protective factors against CVD.
- The Lipid Energy Model (LEM): In a state of constant fat burning (like ketosis) in a very lean, active individual, the body needs to transport a lot of fat for energy. LDL particles are essentially "delivery trucks" for fat. The LEM proposes that in LMHRs, the very high LDL-C isn't due to malfunctioning particles getting "stuck" and causing plaque, but rather a reflection of an efficient and high-volume fat delivery system. They're just very busy "trucks" delivering fuel.
- The Hypothesis: If the other metabolic markers (low TG, high HDL, low inflammation, good insulin sensitivity) are pristine, the high number of LDL particles might not be problematic for plaque formation because the particles are healthy, don't get oxidized easily, and aren't getting trapped in artery walls.
- Applying it to LMHRs: Proponents of this view argue that judging LMHRs by population-wide LDL-C metrics is inappropriate. They believe that their overall metabolic health protects them, and that their high LDL-C is a physiological adaptation, not a pathological one.
Why We Don't Have a Definitive Answer Yet
-
Lack of Long-Term Studies Specifically on LMHRs:
- The LMHR phenomenon has only been widely recognized for a few years.
- To truly "settle" this, we need large-scale, long-term (10-20+ years) studies that track thousands of LMHRs on a keto diet and compare their actual CVD event rates (heart attacks, strokes) with control groups. Such studies are expensive, difficult to conduct, and take a long time.
- Most existing data on LDL-C and CVD comes from studies of the general population, which includes many people who are insulin-resistant, overweight, or have other metabolic issues. LMHRs are a distinct metabolic sub-group.
-
Reliance on Surrogate Markers:
- Currently, researchers are using imaging techniques like Coronary Artery Calcium (CAC) scans and Carotid Intima-Media Thickness (CIMT) to look for early signs of atherosclerosis in LMHRs.
- Preliminary Findings (Small Studies/Case Series): Some small studies and case reports have shown that many LMHRs have a CAC score of 0 (meaning no detectable calcified plaque in their coronary arteries) or very low scores, even with extremely high LDL-C. This is encouraging for the LEM hypothesis, but these are small, observational studies, not definitive proof. A CAC score of 0 does not guarantee that no plaque will ever form, or that soft, non-calcified plaque isn't present.
-
Complex Mechanisms:
- Atherosclerosis isn't just about the number of LDL particles; it's also about their functionality, oxidation, inflammation in the arteries, and other factors.
- The debate is whether the "healthy" metabolic environment of an LMHR (low inflammation, low insulin, low triglycerides) protects the arterial wall from the higher number of LDL particles, or if those high LDL particles will eventually "win out" and cause plaque regardless.
Conclusion for a 12th Grader:
Imagine you're trying to figure out if wearing a specific type of shoe (the "keto diet") is good for running a marathon.
- Most coaches (mainstream medicine) look at a certain reading on a foot pressure sensor (LDL-C). If the reading is high, they say "danger, this shoe will cause injury!"
- A smaller group of new-age coaches (keto proponents/LEM) say, "Wait, look at the runner! They're super lean, their other stats (insulin, triglycerides, HDL) are perfect, and their muscles are really strong. Maybe for this specific runner, that high pressure reading isn't a problem, it's just how they efficiently distribute power. We need to watch them run a few marathons to see if they actually get injured."
So, no one has watched enough of these specific LMHR runners complete enough marathons yet to definitively say whether that high "foot pressure reading" (LDL-C) actually leads to injury (CVD) in their specific case. It's a race that's still being run.
- The Argument: For decades, science has shown a strong link between high LDL-cholesterol (LDL-C) and an increased risk of atherosclerosis (plaque buildup in arteries) and subsequent CVD events (heart attacks, strokes). This link is well-established through:
- User
why was the keto-cta study so controversial. what were the changes to its scope of study. and what were other experts in the field complaining about.
Assistant
Alright, let's break down the Keto-CTA study controversy. Imagine you're in a science class, and a new, exciting experiment gets announced, but then the way it's done changes, and people start yelling about the results. That's a bit like what happened with Keto-CTA.
What was the Keto-CTA Study?
First, let's set the stage. The "Keto-CTA" study was a research effort, primarily driven by citizen scientist Dave Feldman (known for his work on the Lean Mass Hyper-Responder, or LMHR, phenomenon) and medical student (now doctor) Nicholas Norwitz.
Its Big Goal: To examine the arteries of Lean Mass Hyper-Responders (LMHRs) on ketogenic diets to see if their extremely high LDL-cholesterol levels (which conventional medicine usually considers very risky) were actually leading to plaque buildup (atherosclerosis). They used a special scan called a Coronary Artery Calcium (CAC) scan, which looks for hardened plaque in the heart's arteries.
Why Was It So Controversial?
The controversy boiled down to a few key points, mainly concerning the study's design, its limitations, and how its preliminary findings were interpreted and communicated.
1. The Core Clash: Conventional Wisdom vs. A New Hypothesis
- Conventional Wisdom: For decades, the scientific consensus has been that high LDL-C directly increases the risk of heart disease. Statins, drugs that lower LDL-C, are prescribed based on this.
- The LMHR Hypothesis: Dave Feldman and others propose that in LMHRs (lean, healthy, low triglycerides, high HDL on keto), the high LDL-C might be a physiological adaptation (how the body efficiently transports fat for fuel) rather than a pathological risk factor.
- The Conflict: The Keto-CTA study was seen by some as a direct challenge to the established paradigm. If LMHRs with sky-high LDL-C had clean arteries, it would force a major rethinking of cholesterol's role, at least in this specific subgroup. This made the stakes incredibly high and emotions often ran hot.
2. The Big Change: From "Movie" to "Snapshot" (Scope of Study)
This is perhaps the most significant complaint and the root of much of the controversy:
- Initial Hopes/Proposed Scope: When the study was first conceived and discussed publicly, there was a strong implication (or even direct statement) that it would be a longitudinal study. This means tracking the same LMHR individuals over time (e.g., several years) to see if plaque developed or progressed (got worse). This would have been like filming a "movie" of their arteries.
- Actual Study Scope: The study ended up being primarily cross-sectional. This means they scanned a group of LMHRs at one point in time. They looked at the current state of their arteries. This is like taking a "snapshot" of their arteries.
Why this change mattered so much:
- A "snapshot" can't show change: If you take a picture of a house, you know if it's currently built or not. You don't know if it's been there for 50 years, if it was just finished last week, or if it's about to collapse.
- Limited Conclusions: A cross-sectional study can tell you that at this moment, X percentage of LMHRs have a CAC score of 0. It cannot tell you if their keto diet caused them to develop plaque, prevented plaque, or if they just never had plaque to begin with (which is what you'd expect in generally healthy, younger individuals anyway). It doesn't tell you if their high LDL-C is causing future issues.
3. Other Expert Complaints
Beyond the scope change, here's what other experts (especially those from the traditional lipidology community) criticized:
- Small Sample Size: The study ultimately included around 100 participants. While useful for a pilot, this is a very small number for drawing broad, statistically robust conclusions about cardiovascular risk, especially in a unique subgroup.
- Lack of a Control Group: The study didn't compare LMHRs to a similar group of people who weren't on a keto diet, or to keto dieters who weren't hyper-responders. This makes it hard to say if the findings were unique to LMHRs or simply typical for healthy people of that age.
- CAC Score Limitations:
- A CAC score of 0 (no calcified plaque) is good news, but it doesn't mean there's no plaque at all. It only detects calcified plaque. Younger, healthier individuals are more likely to have soft, non-calcified plaque, which can still be dangerous.
- A CAC score of 0 now doesn't predict what will happen in the future, especially if LDL-C remains very high for decades.
- Self-Selection Bias: The participants were volunteers, often highly motivated keto dieters who were likely already monitoring their health closely. This is not a random sample of the population.
- Overstated Conclusions / Public Communication: Critics felt that the results, particularly in the initial public discussions and within the online keto community, were often presented as a definitive "proof" that high LDL-C in LMHRs is benign, despite the study's significant limitations as a pilot cross-sectional study. This led to accusations of "cherry-picking" data or premature conclusions.
- Funding and Transparency: While Dave Feldman was transparent about the citizen-funded nature, some in academia raised questions about the independence and rigor of a study not originating from traditional academic institutions.
In Conclusion:
The Keto-CTA study was controversial because it touched on a fundamental question in health – the role of cholesterol – with a unique, self-selected group, and its design shifted from a potentially definitive "movie" to a more limited "snapshot." While it provided intriguing preliminary data suggesting that some LMHRs on keto might have clean arteries at one point in time, it did not settle whether high LDL-C in this group increases their long-term risk for CVD. It simply generated more questions and highlighted the urgent need for larger, long-term, well-controlled studies.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.